Page 7 - Informatorium Obat COVID-19 di Indonesia
P. 7
DAFTAR ISI
KATA PENGANTAR .......................................................... i
TIM PENYUSUN ............................................................. iii
DAFTAR ISI .................................................................... iv
DAFTAR GAMBAR .......................................................... vi
BAB I PENDAHULUAN .................................................... 1
A. LATAR BELAKANG ................................................. 1
B. TUJUAN .................................................................. 4
C. RUANG LINGKUP .................................................... 4
BAB II PERKEMBANGAN TERAPI COVID-19 DI DUNIA .. 5
A. UMUM .................................................................... 5
B. PERKEMBANGAN TERAPI COVID-19 DI
DUNIA .................................................................. 10
BAB III TATA LAKSANA PENGOBATAN PASIEN COVID-19
DI INDONESIA .................................................... 24
A. UMUM .................................................................. 24
B. PERHATIAN KHUSUS PENGGUNAAN
OBAT UNTUK COVID-19 DI INDONESIA .............. 26
BAB IV INFORMATORIUM OBAT COVID-19 ................. 35
A. ANTIVIRUS ........................................................... 35
1. LOPINAVIR + RITONAVIR ............................... 35
2. FAVIPIRAVIR .................................................. 41
3. REMDESIVIR .................................................. 49
4. OSELTAMIVIR ................................................ 52
B. OBAT ANTIVIRUS PADA PENGGUNAAN
EMERGENSI ......................................................... 57
1. KLOROKUIN FOSFAT ..................................... 57
2. HIDROKSIKLOROKUIN SULFAT ..................... 63
C. ANTIBIOTIKA ........................................................ 73
iv
